Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 7,808 shares at $17.13 ($134K) on 2023-01-09, disclosed to the SEC on 2023-01-10.
Open-market sale of $134k ACAD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.13 | 3,904 | $67K | 50.0% |
| 2 | $17.13 | 3,904 | $67K | 50.0% |
| Total | $17.13 avg | 7,808 | $134K | 100% |
| Filing → |
| ACAD | SELL | 2024-04-09 | $950K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $275K | — | Filing → |